BAUSCH HEALTH COMPANIES INC

NYSE: BHC (Bausch Health Companies Inc.)

Last update: 31 Mar, 8:17AM

6.48

-0.27 (-4.00%)

  • 1D -4.00%
  • 5D 44.00%
  • 1M -7.43%
  • 6M -19.40%
  • YTD -18.39%
  • 1Y -24.83%
  • 5Y -64.22%
Previous Close 6.75
Open 6.71
Volume 1,357,833
Avg. Volume (3M) 2,636,342
Market Cap 2,388,780,800
Price / Earnings (Forward) 1.20
Price / Sales 0.200
52 Weeks Range
3.96 (-38%) — 11.46 (76%)
Earnings Date 30 Apr 2025
Profit Margin -0.48%
Operating Margin (TTM) 23.21%
Diluted EPS (TTM) -0.130
Quarterly Revenue Growth (YOY) 6.30%
Quarterly Earnings Growth (YOY) -61.50%
Current Ratio (MRQ) 0.860
Operating Cash Flow (TTM) 1.60 B
Levered Free Cash Flow (TTM) 1.72 B
Return on Assets (TTM) 4.33%
Return on Equity (TTM) -2,304.54%

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Bearish Mixed
Drug Manufacturers - Specialty & Generic (Global) Bearish Mixed
Stock Bausch Health Companies Inc. Bearish Mixed

AIStockmoo Score

-1.9
Analyst Consensus 1.0
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages -2.5
Technical Oscillators -4.0
Average -1.88

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
BHC 2 B - - -
ZTS 73 B 1.10% 29.87 14.03
TAK 48 B 1,310.58% 34.98 0.890
HLN 46 B 1.57% 24.49 2.28
RDY 11 B 60.20% 17.69 2.98
TEVA 17 B - - 2.87

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Investment Style Mid Value
% Held by Insiders 10.83%
% Held by Institutions 70.44%

Ownership

Name Date Shares Held
Mizuho Markets Americas Llc 30 Sep 2024 7,000,000
52 Weeks Range
3.96 (-38%) — 11.46 (76%)
Price Target Range
8.00 (23%) — 10.00 (54%)
High 10.00 (RBC Capital, 54.32%) Hold
Median 9.00 (38.89%)
Low 8.00 (Jefferies, 23.46%) Hold
Average 9.00 (38.89%)
Total 2 Hold
Avg. Price @ Call 7.00
Firm Date Target Price Call Price @ Call
Jefferies 06 Feb 2025 8.00 (23.46%) Hold 6.54
RBC Capital 30 Jan 2025 10.00 (54.32%) Hold 7.46

No data within this time range.

  • 3M
Date Type Details
22 Apr 2025 Announcement Bausch Health Announces Filing of Supplement to Proxy Statement
17 Apr 2025 Announcement U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
14 Apr 2025 Announcement Bausch Health Announces Adoption of Shareholder Rights Plan
10 Apr 2025 Announcement Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program
09 Apr 2025 Announcement Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris
02 Apr 2025 Announcement Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
27 Mar 2025 Announcement Bausch Health to Announce First Quarter Results on April 30
25 Mar 2025 Announcement Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes
21 Mar 2025 Announcement Bausch Health Announces Conditional Redemption of Senior Notes
19 Mar 2025 Announcement Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities
19 Mar 2025 Announcement Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes
14 Mar 2025 Announcement Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan
19 Feb 2025 Announcement Bausch Health Announces Fourth Quarter and Full-Year 2024 Results
14 Feb 2025 Announcement Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
10 Feb 2025 Announcement Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program
06 Feb 2025 Announcement Bausch Health Provides Update on Strategic Alternatives
Show more
5Y Average Dividend Yield 0.00%
Ex Date Announcement Date Payment Date Details
10 Nov 2010 04 Nov 2010 22 Dec 2010 1 Cash
30 Aug 2010 05 Aug 2010 04 Oct 2010 0.095 Cash
28 May 2010 06 May 2010 05 Jul 2010 0.095 Cash
04 Mar 2010 25 Feb 2010 05 Apr 2010 0.09 Cash
30 Nov 2009 05 Nov 2009 04 Jan 2010 0.09 Cash
28 Aug 2009 06 Aug 2009 05 Oct 2009 0.09 Cash
13 May 2009 06 May 2009 06 Jul 2009 0.09 Cash
06 Mar 2009 26 Feb 2009 06 Apr 2009 0.375 Cash
19 Dec 2008 06 Nov 2008 05 Jan 2009 0.375 Cash
21 Aug 2008 13 Aug 2008 03 Sep 2008 0.375 Cash
20 May 2008 08 May 2008 30 May 2008 0.375 Cash
25 Mar 2008 13 Mar 2008 03 Apr 2008 0.375 Cash
16 Nov 2007 08 Nov 2007 30 Nov 2007 0.375 Cash
16 Aug 2007 08 Aug 2007 31 Aug 2007 0.375 Cash
18 May 2007 10 May 2007 29 May 2007 0.375 Cash
22 Mar 2007 15 Mar 2007 03 Apr 2007 0.375 Cash
08 Jan 2007 06 Dec 2006 22 Jan 2007 0.5 Cash
20 Nov 2006 09 Nov 2006 30 Nov 2006 0.125 Cash
16 Aug 2006 10 Aug 2006 01 Sep 2006 0.125 Cash
19 May 2006 11 May 2006 31 May 2006 0.125 Cash
05 Apr 2006 23 Mar 2006 28 Apr 2006 0.125 Cash
28 Nov 2005 15 Nov 2005 14 Dec 2005 0.5 Cash
15 Nov 2005 03 Nov 2005 01 Dec 2005 0.0775 Cash
17 Aug 2005 04 Aug 2005 01 Sep 2005 0.0775 Cash
11 Apr 2005 10 Mar 2005 27 Apr 2005 0.0775 Cash
10 Jan 2005 29 Dec 2004 26 Jan 2005 0.0775 Cash
08 Oct 2004 01 Oct 2004 27 Oct 2004 0.0775 Cash
12 Jul 2004 30 Jun 2004 28 Jul 2004 0.0775 Cash
12 Apr 2004 03 Mar 2004 28 Apr 2004 0.0775 Cash
12 Jan 2004 19 Dec 2003 28 Jan 2004 0.0775 Cash
06 Oct 2003 15 Sep 2003 29 Oct 2003 0.0775 Cash
09 Jul 2003 01 Jul 2003 25 Jul 2003 0.0775 Cash
07 Apr 2003 04 Mar 2003 23 Apr 2003 0.0775 Cash
06 Jan 2003 20 Dec 2002 22 Jan 2003 0.0775 Cash
09 Oct 2002 02 Oct 2002 23 Oct 2002 0.0775 Cash
08 Jul 2002 01 Jul 2002 24 Jul 2002 0.0775 Cash
08 Apr 2002 14 Mar 2002 24 Apr 2002 0.0775 Cash
07 Jan 2002 19 Dec 2001 23 Jan 2002 0.075 Cash
05 Oct 2001 25 Sep 2001 24 Oct 2001 0.075 Cash
09 Jul 2001 12 Jun 2001 25 Jul 2001 0.075 Cash
09 Apr 2001 23 Feb 2001 25 Apr 2001 0.075 Cash
10 Jan 2001 04 Jan 2001 29 Jan 2001 0.0725 Cash
12 Oct 2000 02 Oct 2000 30 Oct 2000 0.0725 Cash
18 Jul 2000 06 Jul 2000 03 Aug 2000 0.0725 Cash
20 Apr 2000 11 Apr 2000 10 May 2000 0.0725 Cash
25 Jan 2000 18 Jan 2000 10 Feb 2000 0.07 Cash
08 Oct 1999 04 Oct 1999 27 Oct 1999 0.07 Cash
12 Jul 1999 22 Jun 1999 28 Jul 1999 0.07 Cash
12 Apr 1999 22 Mar 1999 28 Apr 1999 0.07 Cash
20 Jan 1999 12 Jan 1999 01 Feb 1999 0.06 Cash
09 Oct 1998 29 Sep 1998 28 Oct 1998 0.06 Cash
06 Jul 1998 24 Jun 1998 22 Jul 1998 0.06 Cash
06 Apr 1998 30 Mar 1998 22 Apr 1998 0.06 Cash
12 Jan 1998 31 Dec 1997 28 Jan 1998 0.08 Cash
06 Oct 1997 29 Sep 1997 22 Oct 1997 0.08 Cash
07 Jul 1997 26 Jun 1997 23 Jul 1997 0.08 Cash
07 Apr 1997 25 Mar 1997 23 Apr 1997 0.08 Cash
11 Feb 1997 31 Jan 1997 27 Feb 1997 0.077 Cash
18 Oct 1996 08 Oct 1996 05 Nov 1996 0.077 Cash
09 Jul 1996 28 Jun 1996 25 Jul 1996 0.077 Cash
26 Mar 1996 14 Mar 1996 10 Apr 1996 0.077 Cash
04 Dec 1995 24 Nov 1995 20 Dec 1995 0.07 Cash
31 Aug 1995 22 Aug 1995 19 Sep 1995 0.07 Cash
23 May 1995 17 May 1995 14 Jun 1995 0.07 Cash
Show more

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2010 1.37 5 4.84
2009 0.930 4 6.66
2008 1.13 3 11.91
2007 2.00 5 14.86
2006 0.500 4 2.36
2005 0.810 5 3.41
2004 0.310 4 1.88
2003 0.310 4 1.44
2002 0.308 4 1.16
2001 0.298 4 0.53
2000 0.288 4 0.74
1999 0.270 4 1.15
1998 0.260 4 2.75
1997 0.317 4 3.25
1996 0.231 3 3.61
1995 0.210 3 3.26
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria